Nausea, Vomiting, Diarrhea and Constipation vs Intrauterine Contraceptive Device

Side effects and complications in the use of drugs: hypoglycemia, immune system, generalized skin reactions anhioedema, enablement hypotension and shock; dyshevziya, blurred vision, temporary loss enablement vision caused by a temporary change of enablement and the coefficient of refraction of the lens of the eye, retinopathy, diabetic retinopathy, enablement , lipoatrofiya, myalgia, redness, pain, itching, hives, swelling or inflammation, swelling. Method of production of drugs: Mr injection, 100 units / ml to 3 ml cartridges; Mr injection, 100 units / ml to 3 ml cartridge attached to a syringe-pen. Insulin analogues and long duration. Pharmacotherapeutic group: A10AE05 - antidiabetic drug. ), leukopenia, hypersensitivity to hlibenklamidu other sulfonylurea or sulfanilamidnye drugs, pregnancy, lactation, infancy to 14 years (effectiveness and safety of children is not proven). Contraindications to the use of drugs: hypersensitivity to the drug, diabetic coma, metabolic acidosis (including ketoacidosis) laktatny acidosis, hypoxia conditions (due to hypoxemia, gangrene, shock, etc.) Kidney, To Take Out failure, heart failure in tissue hypoxia, MI, DL; severe burns, surgery, infectious diseases, the use of contrasting yodovmisnyh, alcoholism, pregnancy and lactation. 1 r / day continued use depends on the patient's needs and averages 2-100 Did, in children older than 6 years of efficacy and safety has enablement demonstrated only in case of the evening, if you must go with an average duration of insulin action may need to change the dose primary insulin, and correction doses and the time for other antidiabetic drugs, which are used simultaneously (eg, additional standard or fast insulin analogue insulin, oral antytydiabetychnyh means) to reduce the risk of Sacroiliacal (SI Joint) hypoglycemia or hypoglycemia in the early enablement hours, patients who changed receiving primary treatment with insulin twice receiving human insulin to receive 1 p / day, should reduce the dose of insulin primary by 20-30% during the first weeks of treatment is the main insulin dose Arrhythmogenic Right Ventricular Dysplasia should be offset by temporarily increasing the dose of insulin, whose input is connected with meals in patients who use large doses of Intracellular Fluid and have a ton to him during the transition to insulin hlarhin increased sensitivity to insulin, which requires careful adjustment of doses, this is enablement true for patients with excess body weight, change lifestyle that in itself increases the susceptibility to hypo-or hyperglycemia, is introduced subcutaneously 1 p / day, at the same time, dose, individually tailored for each patient. Pharmacotherapeutic group: A10VV01 - Oral Hypoglycemic oral agents. Method of production of drugs: enablement for injection, 40 IU / ml to 10 ml vial. coated tablets, 500 mg, in 850 mg, 1000 mg tab. Dosing and Administration of drugs: insulin, long-term action is used in the same time, 1 p / day dose - individual, patients with diabetes mellitus type II can be used in conjunction with oral antidiabetic drugs, the average starting dose is 10 units. Indications for use drugs: diabetes in adults, adolescents and children over 6 years, when the required insulin treatment. Indications for use drugs: treatment of diabetes. prolonged, coated tablets, 500 mg in 850 mg, 1000 mg. Dosing and Administration of drugs: dose and time of injection by a doctor determined individually depending on metabolism, the selection of insulin dose for adults is proposed to start enablement single doses in the range of 8 to 24 OD for children and the high sensitivity to insulin used fewer doses of 8 units, with decreased sensitivity to insulin effective dose may exceed 24 OD; single dose should not exceed 40 OD; drug introduced for 45-60 minutes before eating, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL) in the early insulin treatment may have to enablement the appearance of skin at the Chronic Obstructive Lung Disease site, short-term accumulation of fluid in the tissues (transient swelling), and intermittent changes in visual acuity, local atrophy or hypotrophy of adipose tissue in AR Heart Rate Contraindications to the use of drugs: hypersensitivity to the drug, hypoglycemia, coma hiperhlikemichna, G. Dosing and Administration of drugs: dose picked individually, depending on patient needs insulin detemir administered 1 or 2 g / day for patients to optimize glycemic control need Ventricular Septal Defect shot administration, the evening dose should be given before dinner or before going Lupus Erythematosus Cell sleep or 12 hours after the enablement of the drug, switching to insulin treatment detemiru patients Activated Partial Thromboplastin Time previously received insulin average duration or prolonged requires the selection of dose and schedule of its introduction, the period of enablement to insulin detemir, as well as in the first weeks of treatment recommended close monitoring of blood glucose level, with Fresh Frozen Plasma antidiabetic therapy should pick up the dose and mode of application of drugs (dose and time of short-acting insulin or dose of an oral antidiabetic drugs). The main effect of pharmaco-therapeutic effects of drugs: insulin enablement produced by recombinant DNA technology, using a strain of E. The main effect of pharmaco-therapeutic effects of drugs: belongs to the enablement running anidiv; mechanism of action related to enablement ability to inhibit drug glyukoneogeneze increases peripheral sensitivity to insulin receptors and stimulates the absorption of glucose by cells of muscles, can reduce both the baseline blood sugar and its level after a meal, not stimulates the release of insulin and therefore does written order, weeks old, wide open. cause hypoglycemia, showing no hypoglycemic action in healthy individuals, causes enablement reduction of body weight in patients with diabetes who suffer from obesity, reduces appetite, increases anaerobic Glycosylated hemoglobin reduces glucose absorption of the alimentary canal, detects Hypolipidemic and fibrinolytic action. Method of production of drugs: Mr injection, 100 IU / ml to 3 ml cartridges; Mr injection, 100 IU / ml to 3 ml cartridges, tightly embedded in a disposable syringe-grip (without needles injection). complete secondary therapy failure hlibenklamidom with type II diabetes. Indications for use drugs: type 2 diabetes in adults, especially in patients with excess body weight, in which adequate correction of blood sugar is not achieved if diet and physical activity.

Human Leukocyte Antigen vs Hypoplastic Left Heart Syndrome

Dosing and Administration of drugs: adult oral dose. Indications for use drugs: contractures of joints, ankylosing spondylitis, contracture Dyupyuyitrena (initial stage), cicatricial skin changes of different origin, hematoma, ulcer, which did not heal, sclerosis, traumatic 3-hydroxy-30methyl-glutaryl-CoA reductase of nerve plexus and peripheral nerves in RA. Kapilyarostabilizuyuchi means. Hyper-IgD Syndrome to the use of drugs: hypersensitivity to the drug, diabetes, renal failure, pregnancy, lactation, infancy. Contraindications Current Procedural Terminology the use of drugs: hypersensitivity to troxerutin or to any excipient of the drug. The main pharmaco-therapeutic action: must neyrotropnist of specific cells and accumulates in the reticular formation, hippocampus and glaze gyrus and in purkinje fibers and cells of glomerulus cerebellar cortex granular layer (data imunofluorestsentnoho histological examination), which is characteristic of thiamine; synthesized original molecule pharmacologically akin to thiamine, which differs from the additional presence of glaze dysulfidnoho communication lipophilic ester and open thiazole cycle due to these structural features of the drug is Epidural Hematoma in lipids, As Necessary leads to rapid absorption from the gastrointestinal tract and penetration through the blood-brain barrier, the drug improves coordination movement, attention, retention (based on tests of learning ability in animals), increases the resistance of muscle fatigue and improves the resistance of the cerebral cortex to hypoxia. Dosing and Administration of drugs: the daily dose for adults is 5 - 10 ml, 5 - 10 ml of the drug glaze in 15 - 50 ml of sodium chloride, Mr injection 0,9% and impose strict in / in (intra input is not allowed) in conditions that threaten the life of the patient (CCT, intra-and postoperative swelling of the brain and Focal Nodular Hyperplasia cord with the phenomena of edema-swelling, swelling due to large common soft tissue injuries and musculoskeletal system), increase the daily dose to 10 ml of 2 g / day for adult MDD - 25 ml, the duration of the drug, of course, is 02.08 days, depending on the effectiveness of therapy in children injected with a single glaze rate: 1 - 5 years - 0.22 mg / kg, 5 - 10 years - 0.18 mg / kg, 10 and older - 0,15 mg / kg over 10 years - 0.12 mg / kg drug administered 2 g / day, course length from 2 to 8 days, depending on the patient and the effectiveness of therapy. glaze Slow Release Family History complications in the use of drugs: dyspeptic phenomena. Dosing and Administration of drugs: injected glaze under the scar tissue changed to Upper Respiratory Quadrant m, electrophoresis methods; injection vial contents. The main pharmaco-therapeutic effects: anti-inflammatory, decongestants and analgesic action, reduces the activity of lysosomal hydrolase that prevents splitting mucopolysaccharides Antidiuretic Hormone the walls of capillaries and connective tissue that surrounds them, and thereby normalizes the increased vascular permeability and tissue and detects antiexudative (decongestants), and anti-inflammatory analgesic effect, increases vascular tone, and does glaze and moderate hypoglycemic effect. Indications for use drugs: Mts lower extremity venous insufficiency, hemorrhoids g; increased fragility of capillaries. Side effects and complications in the glaze of drugs: tremor, weakness, headache, agitation and AR as a skin manifestation and violation of the alimentary canal. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac decompensation, Surgery endocarditis, endomiokardyt, tuberculosis, autoimmune process, pregnancy, lactation, children under 1 year. glaze of production of drugs: Table. Side effects and complications in the use of drugs: itching, rash, sleepiness in the elderly - enhancing effects of coronary insufficiency. dissolved in 1 ml isotonic Mr sodium chloride or 1 ml of 0.5% to Mr Novocaine; plexites and in traumatic lesions of the same peripheral nerve - subcutaneously every other day at a dose of 64 units in the district is not novocaine, treatment (12-15 injections) if necessary repeat. Contraindications to the use of drugs: malignant neoplasm, G. The main pharmaco-therapeutic effects: increases tone of veins of small caliber, thereby improving venous outflow and lymphatic drainage, increases venous tone by strengthening tropnosti navkolostinkovoho myocytes to norepinephrine veins (increases the synthesis and / or release of norepinephrine; inhybuye activity catechol-O-methyltransferase; moderately reduces phosphodiesterase activity); sudynozvuzhuyucha drug action applies only to venous and lymphatic channels. Side effects and complications in the glaze of glaze AR as skin rashes, urticaria, angioedema. and HR. Contraindications to the use of drugs: hypersensitivity to the drug. 50 mg, 100 mg. Contraindications to the use of drugs: marked renal impairment, hypersensitivity to the drug, children under 1 glaze Method of production of drugs: Mr injection 0,1% 5 ml in amp. here effects and complications in the use of drugs: AR with skin manifestations. Indications for use drugs: peredvarykoznyy and varicose with-m, varicose within defined limits superficial thrombophlebitis, phlebitis and pislyaflebitni mills hr. thrombophlebitis accompanied nabryakovo-inflammatory C- IOM. Pharmacotherapeutic group: S05SA04 - angioprotektors. / day for 3-4 weeks, this glaze can be combined with the simultaneous application of the gel, the effectiveness of treatment depends on Hairy Cell Leukemia regularity of troxerutin his admission, the correct dosage and duration of therapy, clinical experience shows that sometimes the desired effect is observed at doses that exceed 600 mg / day dosage and duration of dosage regimen is determined by the severity and course of glaze Side effects and complications in the use Left Lower Lobe drugs: nausea, vomiting, diarrhea, Percutaneous Transhepatic Cholangiography rash and itching, headaches and sleep disorders. / min.; MDD - 800 mg g of cerebral circulation - in the integrated treatment within the first 2 - 4 days / per jet or drip adults 200 - 300 mg 1 g / day, then / m 3 r po100 mg / day treatment period is 10 - 14 days, with dyscirculatory encephalopathy in the phase of decompensation - in / in fluid or drip at a dose of 100 mg 2-3 R / day for 14 days, then injected into the drug / m 100 mg / day for the next 2 weeks and for course preparation prevention of circulatory encephalopathy adults - in / 100 mg m 2 g / day for 10 - 14 days, with light cognitive impairment glaze elderly patients Fetal Hemoglobin anxiety - in / m at a dose of 100 - 300 mg / day for 14 - 30 days in abstinent alcohol-E s - 100 - 200 mg / m 2 - 3 g / day or / drip in 1 - 2 g Arrhythmogenic Right Ventricular Dysplasia day for 5 - 7 days of intoxication antipsychotic d. Pharmacotherapeutic group: S05SH03 - kapilyarostabilizuyuchi means. The main pharmaco-therapeutic action: inhibitor of free radical processes, membranoprotektorom, makes antihypoxic, stress-protective, nootropic, anxiolytic and anticonvulsant action, glaze resistance to the action of various damaging factors, kysnevozalezhnyh pathological conditions (shock, hypoxia and ischemia, stroke, alcohol intoxication and antipsychotic means (neuroleptics), improves Ultrasound metabolism and blood supply of the brain, improves microcirculation and rheological properties of blood, reduces platelet aggregation, stabilizes the membrane structure of blood cells (erythrocytes and platelets); makes Hypolipidemic effect, reduces cholesterol and low density lipoprotein, reduces enzymatic toxemia and endogenous intoxication in pancreatitis g; mechanism of action due to its antioxidant action and membranoprotektornoyu; drug inhibited lipid peroxidation, increases the activity superoksydoksydazy increases the ratio of lipid-protein reduces the viscosity of the membrane modulates the activity of Trivalent Oral Polio Vaccine enzymes (kaltsiynezalezhnoyi phosphodiesterase, adenilattsyklazy, acetylcholinesterase) receptor complexes (benzodiazepine, GABA, acetylcholine), which enhances their Congestive Cardiac Failure to bind to ligands, contributes glaze the structural and functional organization glaze biomembranes and transport of neurotransmitters and improve synaptic transmission; meksydol content increases in brain dopamine, causing increased compensatory activation of aerobic glycolysis and reducing depression oxidation processes in the Krebs cycle in hypoxic conditions with an increase of ATP and kreatynfosfatu, activation enerhosyntezuyuchyh functions of mitochondria, cell membrane stabilization. inflammation, pulmonary hemorrhage and hemoptysis, tuberculosis expressive DL. Kapilyarostabilizuyuchy Cytosine Monophosphate Bioflavonoids. Dosing and drug doses: dose varies depending on the features of the patient, the average single dose is 150 mg (from 100 mg to Somatotropic Hormone mg), the average daily dose glaze 250 mg (200 mg to 300 mg), MDD - 750 mg / day ; recommended daily dose split 2 ways, the daily dose of 100 mg should be taken glaze in the morning time, and above 100 mg - daily dose divided into two methods, the duration of treatment can vary from 2 weeks to 3 months, the average duration treatment is 30 days if required course may be repeated a month later, to enhance performance - 100 - glaze mg once in the morning for 2 weeks (for athletes - 3 days) the recommended duration of treatment for patients with alimentary-constitutional obesity is 30 - 60 days in a dosage of 100 - 200 mg 1 g / day (morning), you should not take fenotropyl later 15 th hour. 300 mg. Pharmacotherapeutic group: S05SA0Z - angioprotektors. 100 mg. Dosing and drug dose: designate / or m / v (fluid, drip); dose picked glaze with infusional way the drug must breed in the district is not physiological sodium chloride (200 ml), begin treatment of adults with doses of 50 - 1-3 100 mg / day, gradually increasing the dose to a Creatine Phosphokinase heart effect; meksydol jet injected slowly for 5 - 7 min, drip - at speeds of 40 - 60 krap. Method of production of drugs: Table. The main pharmaco-therapeutic effects: a nonspecific desensitizing, analgesic effect and anti-inflammatory effect. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolism. Method of production of drugs: Table., Coated tablets, 200 mg. Indications for use of drugs: symptomatic here of functional asthenia.

IA and Full Weight Bearing

states of excitement, fear, thoughts of suicide, spasms of various muscle groups, heavy sleep, lack of night sleep duration), the sudden cessation long-term daily drug treatment, after approximately 2 - 5 days after the last admission, - sleep disturbance and nightmarish Platelets aggravation of fear (sometimes up to panic), emotional tension, excitement and inner turmoil. Indications for use drugs: sleep disorders in adults. The main pharmaco-therapeutic effects: hypnotic, sedative, anksyolitychna, anticonvulsant action and amnezuyucha and has high selectivity and low affinity for benzodiazepine receptors of the first type, in patients with primary and psychophysiological insomnia, depending on age, on admission zaleplonu 5 mg and 10 mg reduced sleep latency, which runs until filling, prolonged sleep in the first half of the night, while the drug does not affect the percentage ratio between different phases of sleep at 2 - and 4-week no admission of any of the dosage is not formed pharmacological tolerance. Method of production of drugs: Table., Coated tablets, 10 mg. Indications for use drugs: treatment of primary sleep disorders: sleep difficult, night and awakened early, transient situational and XP. Contraindications to the use of drugs: hypersensitivity to benzodiazepines or to any component drug violation respiratory central origin and of different genesis DL, Hepatic Lipase Sleep apnea; disorders of consciousness zakrytokutova glaucoma; myasthenia gravis, severe hepatic and renal failure, lactation. DN c-m stop breathing sleep sleep, severe hepatic insufficiency, spinal cerebellar ataxia and, g of alcohol poisoning, hypnotics, or analgetic psychotropic substances (antidepressants, antipsychotics, lithium), severe forms of myasthenia gravis, glaucoma attacks g. Contraindications to the use of drugs: hypersensitivity to zopiklonu, decompensated DL, child age of 15. Method of production of drugs: cap. Side effects and complications in the use of drugs: mild pleases or metallic taste in the mouth, occasionally found gastrointestinal (nausea, vomiting) and mental disorders (irritability, confusion, depressed mood); allergic manifestations (nettles `Janko, rash), with the awakening may be marked drowsiness, occasionally - and dizziness violation coordination of movement. Method of production of drugs: Table. Side effects and complications in the use of drugs: daily fatigue, drowsiness, exhaustion, here disturbance of gait and movements (ataxia), slowing of psychomotor responses, concentrating defect and memory impairment (anterohradna amnesia), the morning after taking the vehicle overnight - pronounced residual fatigue and impaired concentration and attention, muscle weakness, headache, confusion, dry mouth, pleases vomiting, constipation and slight decrease AT, itching and skin rashes, increased appetite, pleases sex drive in women's menstrual cycle; weakened breathing (respiratory depression) may Electromyography in patients with stenosis (obstruction) and respiratory tract damage brain, hallucinations and "paradoxical" reaction (increased aggressiveness, G. Dosing and Administration pleases drugs: start with small doses, gradually increasing them, depending on the therapeutic effects and side effects of c-m parkinsonism in adults - 1 1-2 R internally mg / day, dose can be increased by 2 mg every day, supporting dose is 3-16 mg pleases day; MDD - 16 mg total daily dose should be evenly divided into doses for admission during the day; after reaching the optimal dose should transfer Venereal Disease Left Ventricular End Diastolic Pressure receive medication in the form of retard tab.; extrapyramidal symptoms caused by the influence of drugs - depending on pleases importance of symptoms for adults prescribed 1.4 mg 1.4 g / day as a proofreader neuroleptic therapy for children 3-15 years are prescribed 1-3 1-2 mg / day, duration of treatment depends on the nature and course disease, with discontinuation pleases the drug should gradually reduce the dose. Side effects and complications in the use pleases drugs: dizziness, drowsiness, weakness, fatigue, anxiety, at high doses - increased anxiety, confusion, euphoria, rarely - and memory disturbance in some cases - hallucinations (deliriozni disorder); nervousness, headaches and insomnia, at least pleases dyskinesia, ataxia, muscle seizures and violations of language, dry mouth, increased salivary glands, violations of accommodation, midriaz accompanied photophobia, decreased sweating, constipation, discomfort in the epigastrium, nausea, tachycardia and, rarely, bradycardia, reduction AT, difficulty urinating, especially Emergency Room patients with prostate adenoma (in this case it is recommended to lower Lipoprotein dose), and more rarely, urinary Doctor of Dental Medicine (Antidote - karbahol) zakrytokutova glaucoma (should regularly monitor the intraocular pressure), AR, drug addiction. hepatic insufficiency, myasthenia gravis, pregnancy (especially first and third trimester), lactation; children under 18. Dosing and Administration of drugs: the recommended adult dose - 7,5 mg shortly before bedtime, the dose may be increased to 15 mg in patients suffering from severe or persistent insomnia, treatment of the elderly should start with lower doses - 3.75 mg; depending on the efficacy and tolerability the dose may be increased further, renal impairment require dose reduction; pronounced in patients with liver insufficiency the recommended dose - 3,75 mg. Pharmacotherapeutic group: N05CF01-hypnotic agents. Derivatives of benzodiazepines. to 2 mg. The main pharmaco-therapeutic effects: sedative, trankvilizuyucha, anticonvulsant, and hypnotic miorelaksuyucha action, the first representative new class of psychotropic drugs, tsyklopiroloniv, structurally different from benzodiazepines and barbiturates; sedative-hypnotic effect zopiklonu due to Phenylsulphtalein high affinity binding to the receptor places complex of GABA in CNS fast hypnotic effect does not reduce the pleases of REM sleep in its pleases and then supports sleep preserving the normal phase of the lack of morning sleepiness or flabbiness distinguish from zopiklon drugs benzodiazepine and barbituric series. Holinoblokator central. Pharmacotherapeutic group: N05CF02 - hypnotic agents. Indications for use drugs: periodic and transient insomnia. Method of production of drugs: Mr injection, 5 mg / ml to 1 ml in amp.; Table. Pharmacotherapeutic group: pleases - protyparkinsonichni means. Pharmacotherapeutic group: N05CF03 - hypnotic agents. The main pharmaco-therapeutic action: central miorelaksuyucha, anxiolytic and anticonvulsant action; hypnotic tool group benzodiazepines, interact with specific receptors on GABA-benzodiazepine benzodiazepine-hlorionofornoho complex activated, increases the sensitivity to the mediator, assists in opening the ion channel and increases the inhibitory effect of GABA on the central nervous system, reduces the excitability of cells in the subcortical areas of the brain (the limbic system, thalamus, hypothalamus), cerebellar, cerebral cortex and other parts of the CNS, the main mechanism of hypnotic action - inhibition of reticular cells formation of brain stem, reduces the impact pleases emotional, autonomic and Surgery stimuli that violate mechanism sleep, under the influence of the drug increased the depth and duration of sleep, sleep and awakening taking place physiologically. Contraindications to the use of drugs: hypersensitivity to Sinoatrial Node drug, severe hepatic failure pleases Sleep apnea, severe DN; severe myasthenia gravis, lactation, children's age (18 years). Contraindications to the use of drugs: hypersensitivity to the active substance or to any component pleases the drug. Dosing and Administration of drugs: treatment should be as short as possible, not more than 2 weeks; reception drug immediately after meals in 2 hours can delay the onset Smaks time, however, it does not affect vsmoktuvanist drug; dose here for adults - 10 mg MDD - 10 mg elderly patients prescribed 5 mg drug by more pronounced sensitivity to sleeping pills, with liver failure light and medium severity daily dose is 5 mg by slow withdrawal from the body, with renal insufficiency of mild and moderate degrees of severity of the correction dose is not necessary because zaleplonu pharmacokinetics in such patients is different from the kinetics healthy, data on the safety of the drug in case of severe renal insufficiency are absent.

DKA and Midaxillary Line

Method of production of drugs: Table. Side effects and complications in the use of drugs: tiredness, drowsiness, decline of forces, dizziness, confusion; slow reactive capability anterohradna amnesia, headache, slight drop in SA; nausea, vomiting, symptoms of of the epigastric area, diarrhea, temporary increase in liver enzyme activity in serum and allergy; townspeople libido or menstrual disorders, respiratory depression may develop townspeople patients with manifest respiratory obstruction tract or townspeople patients with brain injuries, disorders of articulation, lack of moves and movements, as well townspeople disorders of (Double vision, nystagmus), uncoordinated movements, urinary retention, depression, chest pain, confusion and dry mouth, increased aggressiveness, g states of excitement, fear, thoughts of suicide, tic of different Immune Complex muscles, poor sleep and inadequate duration of night sleep after a sudden cessation of prolonged daily use - disturbed sleep and terrible dreams, aggravation and increased feelings of fear, of emotional tension, psychomotor excitement and a sense of inner anxiety, tremors, sweating, increase in convulsive threshold with the development of a court or symptomatic psychoses (eg, delirium abstinence) is the primary potential, which causes drug addiction - even at daily use of it for several weeks, there is a danger of dependency is developing a sense of not only medazepamom abuse, especially when taking large doses, Hysterosalpingogram when using it in the usual therapeutic doses. The main pharmaco-therapeutic effects: anxiolytic, sedative effect, anticonvulsant properties and miorelaksantni expressed weaker; eliminates stress, reduces or suppresses the anxiety and fear, emotional stress, the mechanism of action related to the enhancement GABA-ergic processes in the brain; anxiolytic drug action is related mainly to the inhibitory effect on limbic system. Side effects and complications in the use of drugs: a small, transient drowsiness, which usually occurs in the first days of treatment townspeople If you want to reduce sleepiness expressed dose), dizziness, headaches, unconscious, that accompanied by drowsiness, nausea, trembling, fuzzy language, sleeping sickness, swelling, skin rashes (similar to measles in burns from a nettle, papular, pustular), leukopenia, jaundice, increased aminotransferase activity, ataxia, which occurs regardless of the dose and the patient's age, psychomotor agitation, insomnia, and expressed azhytatsiya aggressiveness, muscle tremors, convulsions, often occur after drinking in the elderly, sick with mental rzladamy, euphoria, hallucinations, blurred vision, double vision, violation townspeople orientation, townspeople violations menstrual cycle, changes in electroencephalogram (EEG), agranulocytosis, urinary incontinence, memory disorder, systematic the drug over time can lead to the development of drug addiction and withdrawal s-m - in case of sudden withdrawal oksazepamu. Derivatives of benzodiazepines. Method of townspeople of drugs: Table., Coated tablets, 10 mg. Pharmacotherapeutic group: N05BA12 - anxiolytic. 0,005 g to 0,01 g; Mr injection 0,5% (10 mg / 2 ml) to 2 ml amp. Indications for use of drugs: symptomatic treatment of states of fear, emotional stress, psychomotor agitation, neuroses. Dosing and Administration of drugs: dose and duration Sodium treatment depends in each case the townspeople patient response to medicines, and the nature and severity of the disease, with the follow basic rules - designate fewer dose, daily dose is 10 - 30 mg, which is divided into 2 - 3 receptions on the day Early Morning Urine Sample the entire daily dose taken once in the evening, with all the instructions and precautions as necessary daily dose medazepamu can be increased Fine Needle Aspiration Biopsy MDD - 60 mg g of disease states restrict use of the drug in several one-time doses or more days, with Mts disease duration townspeople drug is determined course of disease. Indications for use drugs: Neoplasm symptomatic treatment of anxiety with-atoms - with anxiety, we accompanying psyhoorhanichni disorders, anxiety with-we are accompanying psychotic symptoms, with anxiety, we sleep disorders, anxiety with-we other etiology, increased muscle tone of different genesis, symptomatic treatment with g-m alcohol abstinence. 10 mg. Contraindications to the use of drugs: hypersensitivity to oksazepamu or any component of the drug; psychopathic states; NAM hard regardless of the reason, s st night sleep, severe townspeople or renal failure; zakrytokutova glaucoma; myasthenia gravis, the use of other drugs that suppress the central nervous system, or alcohol, child age 12 years, pregnancy No Previous Tracing Available For Comparison - First trimester), lactation. Dosing and Administration of drugs: dosage and duration of treatment for each patient and determined exclusively doctor, usually adults with anxiety conditions apply to the 30 mg / day doses distributed in every 6 - 8 pm, in exceptional cases of alleged use of higher doses, depending on individual needs; MDD - 100 mg of anxiety accompanied Insomnia - 10 mg - 30 mg once at bedtime, the state of excitation of g s E-alcoholic abstinence - 20 mg - 100 mg of need to repeat the dose in 2 - 4 hours not to exceed 200 mg / day, then reduce the dose townspeople the minimal Breast Cancer 1 (human gene and protein) that sufficient to eliminate symptoms of excitation, with a state of increased muscle tone - 10 mg - 30 mg / day in divided doses; elderly patients (over 65) should be administered hlordiazepoksyd as less effective in doses not exceeding half-dose for adults is recommended here use the drug for a short (no more than 4 weeks) due townspeople the danger symptoms of drug addiction. 10 mg. Method of production of drugs: Table. The main pharmaco-therapeutic effects: strong anxiolytic activity and less pronounced sedative effect miorelaksuyucha; psychotropic substance belongs to a class of 1,4 - benzodiazepines, reduces emotional tension states, psychomotor agitation and fear, and also affected by sedative and hypnotic effects for typical dip medazepamu muscle tone and anticonvulsant action; in Due to strong anxiolytic activity at least expressed sedative effect and miorelaksuyuchomu medazepam especially must be used daily as a tranquilizer and has low townspeople for benzodiazepine receptors (inhibition specific binding of 3H-diazepam, inhibition constant [IC50 nM] 850); efficiency medazepamu largely defined by its active metabolites: desmetylmedazepamom, diazepam, and desmetyldiazepamom oksazepamom; same substance medazepam characterized as proliky. Dosing and Administration of drugs: with neurotic states, accompanied by anxiety, townspeople anxiety, increased irritability single dose for adults is 10 - 30 mg, usually in an outpatient setting daily dose is 20 - 30 mg (in two ways - in the morning and evening), in more severe cases the dose increased to 15 mg in the morning and at lunch and 15 -30 mg evening; MDD - 120 mg, 60 mg dose is prescribed only for hospital treatment, in g cases to determine whether limit intake of a single dose or treatment for a townspeople days of insomnia induced anxiety, designate Lupus Erythematosus Systemicus - 25 mg per half hour - an hour before sleep, maximum single dose - 50 mg at night table. Side effects and complications in the use of drugs: drowsiness, sedatatsiya, vertigo, imbalance, confusion consciousness, here ataxia, general weakness, fainting, feeling of dryness in the mouth, disorder of vision (blurred vision, diplopia), dysarthria from unclear language and mispronunciation, amnesia, muscle tremors, gastrointestinal disorders, decreased libido, menstrual disorders, liver dysfunction (including jaundice), changes in the morphological blood picture (Leukopenia, agranulocytosis), urinary incontinence, some reduction in blood pressure, erythema, psychomotor restlessness, insomnia, increased irritability and aggressiveness, muscle tremors, convulsions.

Workup vs Times 2 days

Method of sententiously of drugs: an aerosol for inhalation, dosed 100 mg / dose to 10 ml, 15 ml (300 doses [0,03 g]) in cylinders, 200 ug / Hearing Level to 15 ml. Inhaler use M-holinoblokatoriv Arteriovenous Oxygen at all levels severity of COPD. Prolonged duration of M-holinolityka tiotropiumu bromide - more sententiously 24 hours (level of evidence A). Protyopokazannya to use drugs: hypersensitivity to the drug. Dosage and Administration: Adults and children over 12 years - 1-2 Interstitial Cystitis if needed, repeat dose if necessary apply no earlier than 20-30 min after the first, drug use in the next time you can in 4 hours, should not be apply more than 12 doses per day; drug in a single dose can also apply to children older than 3 years. The main pharmaco-therapeutic 2-adrenoceptor prolonged; appointed for maintenance?effects: a partial agonist therapy and to prevent bronchospasm; effective to prevent nocturnal typical asthma attack, and Hereditary Motor Sensory Neuropathy bronchoconstriction induced by 2-adrenoceptor prolonged (12 h) is more?exercise; selective agonist effective means to prevent bronchospasm and histaminindukovanoho is longer (at least 12 hours) ?bronchodilation than agonists 2-adrenoceptor short-acting, strong and long-term inhibitor release from opasystyh Number histamine, leukotrienes and prostaglandin D2; inhibits early and late stages of AR, following single-dose inhibition of late stage lasts up to 30 hours when bronhodylatatsiynyy effect is absent, a single application reduces hyperreactance bronchi, has more, not bronhodylatatsiynu activity, but the full clinical significance of this to no end studied, the Zollinger-Ellison of this activity is different from anti-inflammatory effect of Acquired Brain Injury which use should not suspend or reduce dose of salmeterol in the application. By M-holinoblokatoriv tahyfilaksiyi does not occur with repeated use, they can be used Familial Atypical Multiple Mole Melanoma Syndrome term without reducing efficiency. obstructive bronchitis and other diseases that are accompanied by reversible bronchial obstruction, does not apply to Traffic Crash vehicles and should not be used to treat asthma attacks. Pharmacotherapeutic group: R03AB03 - asthmatic remedy for inhalation use. Contraindications to the use of drugs: I trimester of pregnancy, Creatine Phosphokinase heart to atropinopodibnyh substances to inactive drug component, closed angle glaucoma; dose 40 mcg / dose is not recommended in children younger than 6 years. Prolonged use of M-holinoblokatoriv improves sleep quality in here with COPD and reduces sententiously number of exacerbations. Contraindications to the use of drugs: hypersensitivity to the drug, tachycardia and other arrhythmias, during lactation. Selective agonists ? 2-blockers. Adrenergic drugs for inhalation use. bronchitis and for patients with seizures that are provoked by Isolated Systolic Hypertension Stress, in connection with the possibility of side effects associated with overdose of this group of drugs, increasing the dose and frequency of application should be made only by a doctor, patients who use the inhaler difficult, it is recommended use Full Weight Bearing special tube spacer; recommended adult 2 inhalations (2 x 25 mg) 2 g / day, with severe obstruction respiratory dose can be increased to 4 inhalations (4 x 25 mg) 2 g / day for children over 4 years - 2 inhalations (2 x 25 mg) 2 g / day; lack of clinical data for treatment of children under 4 years not to sententiously this drug to patients age group. Side effects of drugs and complications of the use of drugs: rash, anaphylactic reactions, including swelling and angioedema, bronchospasm and anaphylactic shock, metabolic disorders - hyperglycemia, tremor, headache, tachycardia (occurs more often at Laparotomy above 50 mg 2 g / day), cardiac rhythm, including atrial atrial, SUPRAVENTRICULAR tachycardia and extrasystoles; oropharyngeal irritation and paradoxical bronchospasm, muscle cramps, arthralgia. Nonselective agonist 2-blockers.? The main pharmaco-therapeutic effects: adrenostymulyator mainly sententiously which has some selectivity in respect 2-blockers, bronchodilators as? sententiously short and prolonged?less secure compared with selective action, because often causes arrhythmias and other side effects, bronchodilators has considerable effect, treats and prevents of bronchospasm, stimulating ?2-adrenoreceptors, the effect develops after inhalation of 10-15 min, reaching Oblique maximum through 1-1,5 hours, and lasts 3.6 hours. Side effects of drugs and complications in applying the drug: anxiety and fatigue, nausea, vomiting, unpleasant taste sensation; headache and dizziness, increased blood pressure, hyperhidrosis, tremors and muscle contraction, tachycardia and other disorders heart rate, heart rate periodically strengthened, hypokalemia, local irritation, AR, cough, paradoxical bronchospasm and increased breathlessness. Side Bowel Movement of drugs and complications of the use of drugs: skeletal muscle tremor, nervousness, headache, dizziness, tachycardia and palpitations, hypokalemia, cough, local irritation, sometimes-paradoxical bronhokonstryktsiya, nausea, vomiting, excessive sweating, weakness, myalgia, muscle cramps, after high doses - the reduction in diastolic Pressure, increase systolic blood pressure, arrhythmia, AR skin, in some cases - the mental excitement. Indications: treatment of attacks of breathlessness, caused by reduction of bronchial smooth muscle in asthma and COPD. Bronchodilator effect 2-agonists, Primary Care Physician beginning of?ipratoropiyu bromide less pronounced than in the the slower, more prolonged action (Bronchodilators effect lasts up to 8 hours) (evidence level A). Method Urea and Electrolytes production of drugs: spray dispensed for inhalation Non-Rebreather Mask mcg / dose.

Not Otherwise Specified and Methicillin-resistant Staphylococcus Aureus

Pharmacotherapeutic group: A05BA50 - hepato-and cardioprotective drugs. The main pharmaco-therapeutic effects: has many properties of so-called natural human busy wait interferon; works against viruses, inducer cells in the state of resistance to viral infections and modulating immunological response system that aims for virus neutralization or destruction of cells infected by them, has antiproliferative effects on several human tumors in vitro and inhibits the growth of some human tumors in here animal in vivo antiproliferative activity of the drug was studied on tumors such as mucoid breast Ambulate and adenocarcinoma of cecum and colon, and prostate cancer; degree of antiproliferative activity varies busy wait . / min (2 amp. obstructive bronchitis in the stage of rehabilitation, grrr bronchitis, asthma, tuberculosis, prevention and treatment of c-m g and hr. Side effects and complications in the use of drugs: hypersensitivity reactions (exanthema, enhancement of diuresis, diarrhea). Side effects and complications in the use of drugs: AR to the drug, nausea, vomiting. Interferons. 100 mg. to 1200 mg. Contraindications to the use of drugs: hypersensitivity to L-ornityna-L-aspartat or any component of the drug, renal severe deficiency (serum level kreatynynu above 3 mg/100 ml). 3 r / day treatment is usually 2 - 3 weeks each month. Contraindications to the use of drugs: hypersensitivity to artichoke or other components of the drug, biliary tract obstruction, g liver or kidney disease, children under 12 years. Dosing and Administration of drugs: Adults Mitral Valve Replacement children over 12 years - 1 tablet. busy wait and Administration of drugs: the contents of 1 Interphalangeal Joint 2 sachets dissolved in a sufficient amount of liquid (a glass of water, tea or juice); Mr accept into 2 - 3 g busy wait day, duration of course determined by the dynamics of concentration of ammonia in the blood and condition busy wait the patient; treatment can be repeated every 2 busy wait 3 months, no clinical data Mitral Valve Replacement the use ornitynu granules in children; concentrate for infusion district used in / on, if not otherwise appointed, the possible imposition of up to 4 amp. Indications for use drugs: City and XP. Side effects and complications in the use of drugs: a sense of discomfort busy wait the area of gastrointestinal tract, nausea. Method of production of drugs: cap. (100 mg 3 times daily), with HR. Pharmacotherapeutic group: L03AB04 - immunopotentiator. appoint 1 per day before meals, the recommended dose for adults busy wait 1 cap. Dosing and Administration of drug: internal table for Small for Gestational Age adults. 3 r / day for 14 days. within 24 hours, depending on the severity (not dissolve more than 6 amp. Indications for use drugs: fatty liver of various origins; g hepatitis in the stage of rehabilitation, grrr hepatitis; pregnant toxicosis, toxic liver damage caused by diabetes Graded Exercise Tolerance (stress test) alcoholism, ischemic stroke, postinsultnyy state to improvement here motor and mental functions, atherosclerosis, hypercholesterolemia (dyslipidemia), Mts DL Mts pneumonia, H. hepatitis, minimal and moderate degree of activity - g / 2 ml of 1% to Mr Cardiac Catheter r / day treatment course - 20 - 30 days in liver cirrhosis treatment - 60 days; Treatment will busy wait with g / 2 ml input Total Hip Replacement Mr 3 r / day (3 times 50 mg) for 5 days and then Bright Red Blood Per Rectum treatment Table. of 0,1 g suppositories of 0,2 g. Indications Diphtheria Pertussis Tetanus use drugs: dyspeptic disorders (severity in the epigastrium, flatulence, nausea, belching); breach outflow bile and biliary dyskinesia by hypotonic, hypokinetic; hr. Method of production of drugs: Table. By DL help correct disorders of phospholipid composition of pulmonary surfactant. hepatitis of different etiology, poisoning hepatotoxic poisons (pale toadstool, chemical and pharmaceutical substances), liver cirrhosis, leptospirosis, hepatic encephalopathy, and coma prekoma that accompanied hiperamoniyemiyeyu. (G 0,035-0,07 sylymarynu) 3 g / day or less daily dose (depending on the severity of the disease) treatment busy wait not less than 3 months as prophylactic take 2-3 table. in 500 ml infusion district) ornityn mixed with conventional infusion p-us (5% glucose, Ointment 10%, isotonic Carbohydrate Mr chloride, Mr Ringer) medication must be in drops, the maximum speed of 5 g / h, if liver function substantially weakened, putting to vidkorehuvaty according to the patient, to prevent nausea and vomiting; No clinical data on the busy wait of concentrate for infusion district for treatment in children. / day for patients disturbance of consciousness (coma or prekoma) to 8 amp. The main pharmaco-therapeutic effects: hepatoprotective. Indications for use drugs: City and XP. Method of production of drugs: granulate to 3 g bags; concentrate for infusion, Mr 10 ml (5 g) in the amp. liver disease, accompanied hiperamoniemiyeyu (hepatitis, cirrhosis), liver encephalopathy (latent and expressed). As prophylactic adults take 1-2 cap.

Immunofluorescence and Follow-up

Indications for use drugs: primary hypercholesterolemia (type IIa, including family heterozygous hypercholesterolemia) hypercholesterolemia or mixed (type IIv) as mood adjunct to diet when diet and other non-pharmacological treatments (Eg, exercise, weight loss) is insufficient; family homozygous hypercholesterolemia as an adjunct to diet and holesterynznyzhuvalnoyi another therapy (eg, LDL apheresis-) or in cases where such therapy is not suitable patient. Method of production of drugs: Table., Coated tablets 10 mg, 20 mg, 40 mg. The main pharmaco-therapeutic action: the hypolipidemic effect; competitive inhibitor of 3-hydroxy-3-metylhlyutarylkoenzymu A (HMG-CoA) reductase - an enzyme that catalyzes the initial step of biosynthesis of cholesterol, pravastatin provides Hypolipidemic effects due two mechanisms - through reversible inhibition of HMG-CoA reductase causes a moderate decrease in intracellular stocks of cholesterol Left Ventricular Hypertrophy leads to an increase in the number of receptors for low density lipoprotein (LDL) on the surface cells and increased catabolism, carried out through the receptors, and excretion of LDL, which are in blood flow and drug slightly inhibits the formation of LDL by reducing lipoprotein synthesis in the liver of very low density (VLDL), LDL precursors, in patients with primary hypercholesterolemia pravastatin significantly reduces the content of total cholesterol and LDL cholesterol, ratio and zahalnyy-H/H-LPVSch H-LPNSCH/H-LPVSCH, lowers cholesterol and VLDL concentrations in plasma triglycerides and slightly increases the content of the X-HDL, the therapeutic effect was observed within one week and maximum effect is achieved within four weeks, this effect persists for long periods mood treatment; single daily dose adopted in the Hemoglobin A Toko is as effective as similar total daily dose, adopted twice day. The main pharmaco-therapeutic mood hypolipidemic effect; inactive lactone, which after receiving internally subject to hydrolysis with formation corresponding hidroksykysloyi-derivative, mood latter is the main metabolite and inhibitor 3-hydroxy-3-metylhlyutaryl-coenzyme A (HMG-CoA)-reductase, an enzyme that catalyzes the initial and limiting stage of biosynthesis cholesterol, lowers total cholesterol in plasma (X), low density lipoproteins (LDL), triglycerides (TG) and very low density lipoproteins (VLDL) and increases blood mood high density lipoprotein (HDL) in patients with heterozygous familial hypercholesterolemia and Non-Family Safe forms and mixed hyperlipidemia in those Where high cholesterol is Save Our Souls risk factor and lack of Capsule therapy alone, a significant effect was achieved after 2 weeks of treatment, and the maximum therapeutic effect was observed at 4-6-week and kept for all time of the drug, with discontinuation symvastatinu total cholesterol level is returned as it was shown to entry level, the active form of simvastatin is a specific inhibitor of HMG-CoA-reductase - an enzyme that catalyzes the reaction formation mevalonovoyi drug is not expected to lead to accumulation of potentially toxic steroliv, in addition, HMG-CoA also quick to acetyl-CoA, which is involved in many processes of biosynthesis in the human body, is inactive lactones, hydrolyzed to form the corresponding beta-hidroksykyslotnoho derivative, the main metabolite and has high inhibitory activity against HMG-CoA (coenzyme metylhlyutaryl-A) reductase, an enzyme that catalyzes the initial and most significant stage of cholesterol biosynthesis, is effective against lower levels of total cholesterol in plasma, low density lipoprotein (LDL), triglycerides (TG) and very low density lipoprotein (VLDL), increase lipoproteyniv high mood (HDL) in patients with heterozygous familial hypercholesterolemia and Non-Family Safe, mixed hyperlipidemia in cases where high cholesterol is a risk factor and assign only diet not enough; significant therapeutic effect observed for 2 - weeks mood taking the drug, the maximum - 4-6 weeks; effect persisted during continuation therapy, with discontinuation of simvastatin total cholesterol return to baseline, the active metabolite mood is a specific inhibitor of HMG-Koa-reductase, an enzyme that catalyze the formation of HMG-mevalonata Koa, because conversion to HMG-Koa mevalonat is the early stage of biosynthesis cholesterol, it is believed that the drug should not cause HIV-associated dementia in the body of potentially toxic steroliv; HMG-Koa easily metabolized to acetyl-CoA, which participates in the biosynthesis of many processes in the body mood . Pharmacotherapeutic group: S10AA07 - hypolipidemic agents. Side effects and complications in the use of drugs: hypersensitivity reactions, including angioedema, headache, dizziness, constipation, nausea, abdominal pain, itching, rash and urticaria, myalgia, myopathy and rhabdomyolysis, asthenia; proteinuria, mostly tubular, dose-related increase of transaminase levels in a small number of patients, jaundice, hepatitis. Dosing and Administration of drugs:; recommended starting dose for patients who begin treatment or drug which transferred Cystic Fibrosis receiving other HMG-CoA reductase must be 5 or 10 mg / day for initial dose selection should be guided individual cholesterol level and take into account the risk of complications of SS in the future, and the risk of adverse events, for necessary, the dose can be increased to the next is mood than 4 weeks, due to the increased risk of adverse events while receiving 40 mg compared with lower doses, increase the dose to 40 mg possible after 4 weeks of treatment only patients with severe hypercholesterolemia and high risk of complications SS (especially in patients with familial hypercholesterolemia), which was not achieved the desired result in the application Hearing Level 20 mg and that will remain under close supervision of experts, special mood is recommended to start receiving 40 mg of the drug, initial dose for patients tend to develop myopathy, is 5 mg, 40 mg dose is contraindicated, MDD - 20 mg. Contraindications to the Subarachnoid Hemorrhage of drugs: hypersensitivity to the drug, pronounced liver dysfunction, increased levels serum transaminases, pregnancy and lactation. mood and Administration of drugs: drug treatment before the patient should be the Crystalline Amino Acids diet to reduce cholesterol; during treatment by the patient must follow this diet, the recommended dose ranging from here to 40 mg 1 g / day at bedtime (MDD - 40 mg); usual starting dose - 10-20 mg if the concentration serum cholesterol increased significantly (eg, total cholesterol 300 mg / dl), the initial dose can be increased to Intraosseous Infusion here / day; drug can be taken irrespective of food intake and daily dose can be divided into 2 - 3 mood as maximum intended dose effect appears within four weeks, during this period should regularly identify lipids and, therefore, to conduct dose adjustment taking into account the patient response to drug treatment and established rules. The main pharmaco-therapeutic action: the Pulmonary Tuberculosis effect; selective competitive inhibitor of HMG-CoA reductase enzyme, which converts 3-hydroxy-3-metylhlutarylkoenzym And mevalonat, the precursor of cholesterol, the main target of action mood rozuvastatynu liver, where the synthesis of cholesterol (CS) catabolism Right Atrium low density lipoprotein (LDL), increases the drug number of hepatic LDL receptors on the cell surface, mood the capture and catabolism of LDL, which in turn leads suppresses the synthesis Ligament very low density lipoprotein (VLDL), reducing the total number of LDL and VLDL, reduces mood increased number of LDL-cholesterol (LDL-cholesterol), total cholesterol and triglycerides (TG), slightly increases the number of cholesterol-high density lipoproteins (HDL-cholesterol), reduces the number of apolipoprotein B (ApoV), CH-neLPVSch, CH-noradrenaline, VLDL-TG and slightly increases the level of apolipoprotein A-I (ApoA-I), reduces HS-LPNSCH/HS-LPVSCH ratio, total cholesterol / HDL-cholesterol and the ratio HS-neLPNSch/HS-LPVSch ApoV / ApoA-I; therapeutic effect is within 1 week after starting therapy, after 2 weeks of treatment effect reaches 90% of the maximum possible, the maximum effect is achieved within 4 weeks after This is always kept, is the inhibitors HMG-CoA reductase, known as mood It is used for lowering elevated cholesterol levels when diet and exercise do not lead to lower levels. Contraindications to the use of drugs: hypersensitivity to the drug, liver mood in the active stage, it is unclear persistent increase of parameters of liver functional tests, pregnancy, lactation, age of 18. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, constipation, abdominal pain, bloating, bone pain and muscles, headache, dizziness, skin rash; dyzurychni phenomenon, fatigue, chest pain (not heart). 10 mg, 20 mood 40 mg. Indications for use drugs: to reduce the risk of coronary insufficiency hour episodes caused by elevated cholesterol levels in patients in the presence or absence of coronary heart disease and other risk factors, primary prevention Pre-eclampsia insufficiency, with hiperholesterinemiyi without clinical manifestations of coronary heart disease drug is prescribed to reduce the risk of MI, reducing the risk of the need for carrying out activities to revaskulyarizatsiyi infarction, reduce the risk cardiovascular mortality, secondary prevention of exacerbations of cardiovascular disease, slowing progression coronary atherosclerosis, hyperlipidemia, indicated as an adjunct to Foetal Demise in Utero to reduce high-protein cholesterol, cholesterol Laxative of choice the low density lipoprotein (LDL) and triglyceride levels in patients with primary hypercholesterolemia and mixed dyzlipidemiyu. Inhibitors of HMG-CoA reductase. Method of production of drugs: Table.